Virginia (202) 466-6937

Listen to Jonathan Emord on Coast to Coast AM with George Noory (4/8/2021)

Jonathan Emord appeared for two hours on the nationally syndicated radio program “Coast to Coast” with George Noory on April 8, 2021 to discuss the state of individual freedoms in America, specifically as they relate to various government orders, mandates, and restrictions not addressed in the US Constitution.  Mr. Emord is the author of The […]

Jonathan Emord appears on Coast to Coast AM with George Noory

Jonathan Emord appeared for two hours on the nationally syndicated radio program “Coast to Coast” with George Noory on September 9, 2019 from 9PM to Midnight Pacific.  Jonathan discussed the opioid crisis, FDA complicity in the acts of major pharmaceutical companies in promotions that caused it, Trump’s efforts to stem the crisis, the Oklahoma public […]

PRESS RELEASE: Attorney Jonathan Emord Takes on the FDA Over Electroshock (ECT) Device

For Immediate Release Contact:  Dr. Linda Lagemann 415-640-7343 Email:  2DrLagemann@gmail.com Attorney Jonathan Emord Takes on the FDA Over Electroshock (ECT) Device  In December 2015, the FDA issued a proposed order to down-classify the device used to deliver electroshock therapy. Today, Attorney Jonathan Emord filed a Citizens Petition with the FDA on behalf of 5 individuals […]

FTC’s Ban of “Biodegradable” Claims in the ECM Case Threatens an Expansion of FTC Authority (Case Comment)

By Peter A. Arhangelsky, Esq. On October 19, 2015, the Federal Trade Commission issued its Final Decision and Order (“Decision”) against ECM Biofilms, an Ohio-based company that produces additives used in plastics manufacturing.  See In re ECM Biofilms, FTC Docket No. 9358 (Oct. 19, 2015).  A copy of ECM’s press release concerning that decision is […]

FTC Bans “Biodegradable” on Products

In a decision that reverses its Administrative Law Judge and sets new national environmental policy, a Federal Trade Commission decision released on October 19, 2015 forbids the term “Biodegradable” from appearing on any product unless that product is shown to completely break down into elements in nature within five years after customary disposal.  See In re ECM […]

Jonathan Emord Appears on Coast to Coast AM with George Noory to Discuss the Passage of the California Vaccination Bill

Listen to Jonathan Emord’s recent appearance on Coast-to-Coast AM with George Noory.  Jonathan was George Noory’s guest for the first two hours.  He discussed the passage of California’s new vaccination bill, which may substantially reduce the scope of liberty for citizens.  That bill mandates proof of immunization before any child can enroll in public or […]

Jonathan Emord Discusses Vaccines, Personal Rights and Freedoms on Coast to Coast AM with George Noory

Listen to Jonathan Emord’s recent appearance on Coast-to-Coast AM with George Noory.  Mr. Emord was George Noory’s guest on March 17, 2015 for the first two hours.  Jonathan Emord addressed issues relating to vaccines, and personal rights and freedoms.  He noted that the US Government funds a national Vaccine Injury Compensation Program to the amount […]

Biodegradable Plastics Claim Upheld Against FTC Challenge in Precedent Setting ECM BioFilm’s Case

Press Release:  February 6, 2015 For Immediate Release Contact:  Jonathan W. Emord or Peter A. Arhangelsky (202-466-6937) Washington, D.C.–On January 28, 2015, Federal Trade Commission Chief Administrative Law Judge D. Michael Chappell issued a precedent setting decision in the case of FTC v. ECM BioFilms, FTC Docket No. 9358. In his decision, Judge Chappell held […]

Experts Recap Oral Arguments Before the Supreme Court in POM v. Coke

Oral arguments concluded on Monday, April 21, 2014,  in the POM v. Coke (Dkt. No. 12-761) case pending before the United States Supreme Court.  Click here to read what experts had to say about the arguments.  To recap, POM originally challenged Coke’s marketing for Minute Maid “Pomegranate Blueberry” fruit juice blend.  POM filed a Lanham Act […]

Attorney Peter Arhangelsky Comments on Upcoming POM v. Coke Decision

In a recent article appearing in Foodnavigator-USA.com, Emord & Associates’ principal Peter A. Arhangelsky predicts that a broad decision from the Supreme Court this year could limit food and dietary supplement manufacturers’ exposure to consumer suits in plaintiff-friendly states like California.  To get there, however, the Court must hold that the FDA is the exclusive […]


Whether evaluating a concept, performing regulatory due diligence, maintaining or prosecuting regulatory filings, or contesting adverse litigation, Emord & Associates provides exceptional counsel for all your litigation and regulatory needs.

Virginia (Firm HQ)

11808 Wolf Run Lane
Clifton, VA 20124
Telephone: (202) 466-6937
Telecopier: (202) 466-6938